Article Text

Download PDFPDF
EV141/#632  Gynecologic cancer impact accelerator: toolkits to standardize endometrial & vulvar cancer molecular stratification
  1. Nicole Prestley1,
  2. Jessica Mcalpine2,
  3. Michelle Woo3 and
  4. Emily Mckay4
  1. 1Women’s Health Research Institute, Vancouver, Canada
  2. 2BC Cancer Agency, Gynecologic Oncology, Vancouver, Canada
  3. 3BC Cancer Research, Vancouver, Canada
  4. 4University of British Columbia, Obstetrics and Gynaecology, Vancouver, Canada

Abstract

Introduction Canadian-led globally impactful research discoveries for molecular stratification in endometrial (EC) and vulvar (VSCC) cancers are not uniformly implemented. This team aimed to co-create and mobilize toolkits to improve knowledge translation about molecular stratification in EC and VSCC cancers, working to improve equity in cancer care delivery.

Methods The consolidated framework for implementation research (CFIR) informed the design and co-creation of the toolkits. Utilizing CFIR, barriers and facilitators to implementation were identified and discussed by a working group composed of knowledge users, thought leaders and patients. After identifying the key literature to inform content creation, the toolkit was reviewed and submitted for presentation.

Results The toolkits will be presented in June 2024 in partnership with the Society of Gynecologic Oncology of Canada and the Society of Obstetrics and Gynecology of Canada. At this presentation subject matter experts will provide feedback regarding the usability and relevance of the toolkit. Metrics will be collected to describe methods of engagement and to inform strategies for implementation.

Conclusion/Implications These toolkits aim to promote awareness and use of the existing high-quality molecular classification by pathologists, healthcare providers, and patients. Equipping healthcare providers with the essential information to incorporate molecular testing as a standard for care for all EC and VSCC cancer patients will significantly improve the delivery of cancer care in Canada by ensuring reproducible and prognostic results that are predictive in management of disease. It is critical to evaluate these toolkits from an implementation science perspective to adopt them for use in international care settings.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.